Hypersensitivity syndrome induced by anticonvulsants: Possible cross-reactivity between carbamazepine and lamotrigine

Journal of Clinical Pharmacology

Volumn 49, Issue 12, 2009, Pages 1488-1491

  Aouam, Karim ^a   Romdhane, Foued Ben ^b   Loussaief, Chaouki ^b   Salem, Randa ^b   Toumi, Adnne ^b   Belhadjali, Hichem ^b   Chaabane, Amel ^a   Boughattas, Naceur A ^a   Chakroun, Mohamed ^b  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Carbamazepine; Cross reactivity; DRESS; Lamotrigine

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; LACTATE DEHYDROGENASE; LAMOTRIGINE; LIVER ENZYME; MICROSOMAL AMINOPEPTIDASE;

ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; CROSS REACTION; DRESS SYNDROME; DRUG WITHDRAWAL; EOSINOPHILIA; ERYTHRODERMA; FEVER; HUMAN; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PATCH TEST; SIDE EFFECT; SYMPTOM;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CROSS REACTIONS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HUMANS; MALE; PATCH TESTS; SKIN; SYNDROME; TRIAZINES;

EID: 71449122141     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009344985     Document Type: Article

References (16)

1. Sullivan JR, Shear NH The drug hypersensitivity syndrome. What is the pathogenesis ? Arch Dermatol. 2001 ; 137: 357-363.
2. Bocquet H., Bagot M., Roujeau JC Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996 ; 15: 250-257.
3. Begon E., Roujeau JC Drug hypersensitivity syndrome: DRESS (drug reaction with eosinophilia and systemic symptoms). Ann Dermatol Venereol. 2004 ; 131: 293-297.
4. Shear NH, Spielberg SP Anticonvulsant hypersensitivity syndrome in vitro assessment of risk. Clin Invest. 1988 ; 82: 1826-1832.
5. Veyrac G., Marcade G., Chiffoleau A., Bourin M., Jolliet P. Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes. Therapie. 2002 ; 57: 289-296.
6. Knowles SR, Shapiro LE, Shear NH Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf. 1999 ; 21: 489-501.
7. Naranjo CA, Busto U., Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 ; 30: 239-245.
8. Allam JP, Paus T., Reichel C., Bieber T., Novak N. DRESS syndrome associated with carbamazepine and phenytoin. Eur J Dermatol. 2004 ; 14: 339-342.
9. Descamps V., Bouscarat F., Laglenne S., et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol. 1997 ; 137: 605-608.
10. Aouam K., Bel Hadj Ali H., Youssef M., et al. Carbamazepine-induced DRESS and HHV6 primary infection: The importance of skin tests. Epilepsia. 2008 [E-pub ahead of print]
11. Schaub N., Bircher AJ Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy. 2000 ; 55: 191-193.
12. Karande S., Gogtay NJ, Kanchan S., Kshirsagar NA Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Indian J Med Sci. 2006 ; 60: 59-63.
13. Blondin NA, Zahedi S., Hale MS A case of lamotrigine-associated anticonvulsant hypersensitivity syndrome. Prim Care Companion J Clin Psychiatry. 2008 ; 10: 249-250.
14. Maggs JL, Naisbitt DJ, Tettey JN, Pirmohamed M., Park BK Metabolism of lamotrigine to a reactive arene oxide intermediate. Chem Res Toxicol. 2000 ; 13: 1075-1081.
15. Lu W., Uetrecht JP Possible bioactivation pathways of lamotrigine. Drug Metab Dispos. 2007 ; 35: 1050-1056.
16. Romano A., Guéant-Rodriguez RM, Viola M., Gaeta F., Caruso C., Guéant JL Cross-reactivity among drugs: clinical problems. Toxicology. 2005 ; 209: 169-179.